teva-english-logo-gray-web-5-1
Photo: Courtesy of Teva
25 October 2016Americas

Teva sued over opioid overdose drug

Irish pharmaceutical company Adapt Pharma has filed a complaint against Teva for allegedly infringing a patent centring on its nasal spray Narcan (naloxone hydrochloride).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
21 December 2021   A Delaware Federal Court has upheld some of the validity of challenged claims in two patents related to BioDelivery Sciences’ opioid medication Belbuca, but invalidated others.